Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To characterize the spectrum of clinical outcomes achieved with depression treatment and the associated impact on quality of life (QOL), functional status, overall well-being, health-care costs, and productivity. SOURCES: Electronic databases including Medline were searched for English language sources between 1995 and 2007 using key words of depression, nonresponse, partial response, and remission and QOL, functional status, utility, cost, and productivity. STUDY SELECTION: Relevant abstracts were obtained for 488 references and full-text articles were reviewed that included primary data and compared outcomes by treatment response. Data were abstracted from 26 full-text articles. DATA ABSTRACTION: Detailed evidence tables were prepared with the relevant data as well as information on the study design. All data abstracted were checked for accuracy. synthesis: Treatment remitters and partial responders reported clinically and statistically significant improvements in QOL, functional status, and overall well-being compared to nonresponders. Annual health-care costs and productivity losses were significantly lower for remitters and partial responders compared to nonresponders. CONCLUSIONS: The reduced disease burden for remitters and partial responders compared to nonresponders indicates that new treatment strategies that improve the rates of response/remission with initial treatment might have value to patients and to society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700 · cited 1×
“5 of a standard deviation unit) for all these dimensions, which some consider to be the minimal clinically important difference for this scale.([58]) For both the SF-36 and the SAS-SR, improvement in function was also higher than the standard deviation for the baseline value for remitters but similar or less than the…”
BackgroundTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Assessment of social adjustment by patient self report.
Weissman, M. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090101010 · Cited by 1,782 · cited 9×
“Continued Reference Definitions of treatment response and functional status measures Magnitude of functional status gains with treatment by treatment outcome Papakostas et al.[57] (US, N 5 222) Response definitions: Mean decrease from baseline (2.6 SD 0.6) in SAS-SR: Randomized double- blind treatment trial Remission:…”
BackgroundInfluentialHasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1097 · Cited by 1,645
Cost of Lost Productive Work Time Among US Workers With Depression
Stewart, W. F. (2003) · JAMA · doi:10.1001/jama.289.23.3135 · Cited by 1,421 · cited 5×
“Based on results from a prospective observational study by Simon et al.[17] (Spain, Israel, Australia, Brazil, Russia, US, N 5 968) Response definitions: Monthly days missed from work: Prospective observational study Remission (R) (full remission): Not meeting CIDI diagnosis criteria and CES-Do16 Spain: R: 0.4; PR: 0.…”
BackgroundMethodInfluentialThe Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076 · cited 1×
“This health policy focus is illustrated in the US by the implementation of the government-funded Sequenced Treatment Alternatives to Relieve Depression (STAR D) clinical trial([22]) that is designed to determine the relative effectiveness of alternative second, third, and fourth treatment steps for MDD when the first-…”
MethodDEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
Continuity of antidepressant treatment for adults with depression in the United States
Olfson, M., Marcus, S. C., Tedeschi, M., & Wan, G. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.101 · Cited by 392
The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs
Crown, W. H., Finkelstein, S., Berndt, E. R., Ling, D., Poret, A. W., Rush, A. J., & Russell, J. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1102 · Cited by 386
Depression and insomnia: questions of cause and effect
Lustberg, L., & Reynolds, C. F. (2000) · Sleep Medicine Reviews · doi:10.1053/smrv.1999.0075 · Cited by 300
Entsuah, A. R., Huang, H., & Thase, M. E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1106 · Cited by 245
Sapin (2004) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-2-20 · Cited by 161
Evidence review: efficacy and effectiveness of antidepressant treatment in primary care
Simon, G. E. (2002) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00198-6 · Cited by 132
Self-citationCorey-Lisle, P. K., Birnbaum, H. G., Greenberg, P. E., Marynchenko, M. B., & Claxton, A. J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0810 · Cited by 84
Sherbourne, C., Schoenbaum, M., Wells, K. B., & Croghan, T. W. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2003.08.009 · Cited by 47
Cited by
Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression.
Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., Nemeroff, C. B., & The APA Council of Research Task Force on Novel Biomarkers and Treatments (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040465 · Cited by 598
Johnston, K. M., Powell, L. C., Anderson, I. M., Szabo, S., & Cline, S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.045 · Cited by 321
Shim, R. S., Baltrus, P., Ye, J., & Rust, G. (2011) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2011.01.100121 · Cited by 267
Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
Sarnes, E., Crofford, L., Watson, M., Dennis, G., Kan, H., & Bass, D. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.009 · Cited by 258
Vashum, K. P., McEvoy, M., Milton, A. H., McElduff, P., Hure, A., Byles, J., & Attia, J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.016 · Cited by 91
Metadata
- Authors
- Mauskopf, J. A., Simon, G. E., Kalsekar, A., Nimsch, C., Dunayevich, E., & Cameron, A.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2009-01
- Volume
- 26
- Issue
- 1
- Pages
- 83-97
- ISSN
- 1091-4269 (ISSN-L)
- 1520-6394
- OpenAlex
- W2010896339
- Cited by
- 94
- References
- 17
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.